Latest / Behind the Bastards / Part One: The Sackler Family: America's Deadliest Drug Dealers
Transcript
- 0:00Speaker 1: Hmm, what's wagon mattails? I'm Robert Evans. This is Behind
- 0:06Speaker 1: the Bastards. Uh. Sophie is giving me the thumbs up
- 0:09Speaker 1: for that. Intro this podcast, we talked about all the
- 0:11Speaker 1: bad people, stuff you don't know about him, all that
- 0:14Speaker 1: good jazz. My guest with me is James Heeney, actor
- 0:17Speaker 1: comedian James. Welcome to the show. Hi, it's a super
- 0:21Speaker 1: big pleasure to come in here. I've listened to a
- 0:23Speaker 1: lot of episodes. I've spoken towards the speakers in my car.
- 0:26Speaker 1: This is the first time I'm gonna get responses. I'm
- 0:30Speaker 1: really happy about that. Well, I'm I'm glad to hear
- 0:33Speaker 1: that you you shout at my disembodied voice. I like
- 0:35Speaker 1: to imagine thousands of people doing that into their cars
- 0:38Speaker 1: every morning. Whenever I see somebody else talking to themselves
- 0:41Speaker 1: in the car, I imagine they're listening to Behind the Bastards.
- 0:44Speaker 1: So do I, So do I. It's narcissism in my case,
- 0:47Speaker 1: but it's very flattering in yours. Thank you. You know.
- 0:50Speaker 1: I don't want to blow too much time, but I
- 0:52Speaker 1: always start the first episode thinking to myself, Gosh, this
- 0:55Speaker 1: person could be me, and then the second episodes. I'm like,
- 0:58Speaker 1: thank God, there's some distant between myself and this monster. Well, James,
- 1:04Speaker 1: you get anything you want to plug in the p
- 1:05Speaker 1: zone would uh. I'm part of the same network alchemy
- 1:10Speaker 1: this it's twice a week Tuesdays and Thursdays Improv podcast
- 1:14Speaker 1: with Kevin Pollock. Yes, that Kevin Pollock, and specifically we
- 1:19Speaker 1: have a live show at the Dynasty Typewriter Theater on
- 1:22Speaker 1: May seven at eight pm. Gosh, it would be great
- 1:24Speaker 1: if everyone came. It would everyone book a ticket to
- 1:28Speaker 1: l a flood the theater. Do not let them not
- 1:31Speaker 1: see you demand to be let in, bring weaponry, um
- 1:34Speaker 1: force your way in riot. Well, well that might be
- 1:38Speaker 1: be just just crossing a threshold there. Yeah, you might
- 1:41Speaker 1: find yourself in the second episode of Behind the Bastards
- 1:44Speaker 1: with that attitude. We're we're gearing up for that. I
- 1:46Speaker 1: do like to urge crimes every every third or fourth episode,
- 1:49Speaker 1: just just just my little way of thumb in my
- 1:52Speaker 1: nose at the FTC because they can't they can't do
- 1:55Speaker 1: anything about podcasts. I didn't realize they had no control
- 1:57Speaker 1: over there. They don't not over podcasts. It's we're in
- 2:00Speaker 1: international waters of radio. Like it's the there's there's no
- 2:04Speaker 1: law here, there's no maps for these territories. Do you
- 2:06Speaker 1: worry of her that people are going to get your
- 2:08Speaker 1: your tricks? Like I heard some stash tricks about drugs
- 2:11Speaker 1: the other week, and I thought, maybe all the cops
- 2:13Speaker 1: know it now. Yeahs. See, that's part of what I
- 2:16Speaker 1: I worry about, which is why I don't tell my
- 2:18Speaker 1: good stash tricks on the air. But if they're listening,
- 2:21Speaker 1: they've got to be cool, right, Yeah, they've gotta be
- 2:23Speaker 1: cool cops. Threshold of cool that goes along with a
- 2:26Speaker 1: listener behind the past exactly. So we assume that like
- 2:29Speaker 1: those of the cops will let you slide for a
- 2:30Speaker 1: little bit of weed, quarter pound of math or you know,
- 2:33Speaker 1: just like little stuff, you know, okay, quarter pounds a
- 2:36Speaker 1: lot of not if you're not, if you're doing a
- 2:38Speaker 1: lot of maths, that just a couple of weeks. Yeah,
- 2:40Speaker 1: I guess so anyway, Uh, speaking actually of of of
- 2:45Speaker 1: drug dealers. Uh, we're talking about drug dealers today probably
- 2:49Speaker 1: the most successful, wealthiest, uh and deadliest drug dealers in
- 2:54Speaker 1: the history of the world. Have you ever heard of
- 2:56Speaker 1: the Sackler family. I have not heard of the Sackler family.
- 2:59Speaker 1: Have you ever heard of oxyconton? I have heard, Yeah,
- 3:04Speaker 1: I have heard. That's actually not I don't like oxycont
- 3:08Speaker 1: never done it, never done it. I'm free to say
- 3:11Speaker 1: I've done a lot of things, never touched oxyconton. See,
- 3:13Speaker 1: I really like pain killers, and I have messed around
- 3:16Speaker 1: with oxy a couple of times in the past, and
- 3:17Speaker 1: it's one of those things where I won't let myself
- 3:19Speaker 1: buy opiates because I know I would develop a problem,
- 3:22Speaker 1: Like fucking that, because I really enjoy them. I had
- 3:24Speaker 1: an injury when I was early in college and I
- 3:27Speaker 1: had like viking in or whatever, I don't know, maybe
- 3:29Speaker 1: it was coding whatever pill they gave me, but it
- 3:32Speaker 1: wasn't as good as acid, and it wasn't as good
- 3:34Speaker 1: as the other things I was doing, and I was
- 3:36Speaker 1: so worried that it would have a counter effect that
- 3:38Speaker 1: I ended up not taking them. And I think I've
- 3:40Speaker 1: really dodged the bullocks. I've gotten addictive personality. Yeah, it's
- 3:44Speaker 1: that's like one of the ones to really avoid because
- 3:46Speaker 1: that'll that'll fucking kill you pretty fast, which is so
- 3:50Speaker 1: upsetting because it's legal. Yeah, it's super legal, Uh, super
- 3:54Speaker 1: hard to control and really easy to go from, like like,
- 3:57Speaker 1: if you're just taking the pills, that's reasonably safe. It
- 4:00Speaker 1: The problem is people escalate and they start extracting the
- 4:02Speaker 1: oxy from the pills where they move up to fentnel
- 4:04Speaker 1: and then they they kill themselves, and it's like it's
- 4:07Speaker 1: just so hard to moderate, Like it's even alcohol, like
- 4:11Speaker 1: you know, probably on a societal level causes more problems,
- 4:14Speaker 1: but it's harder to kill yourself with um maybe not.
- 4:18Speaker 1: I guess that's you know, it's easier to kill other
- 4:20Speaker 1: people with that ball. So nobody's nobody's ramming a car
- 4:23Speaker 1: into somebody else while they're they're hopped up on oxy.
- 4:25Speaker 1: Probably probably, Actually I would say that. I wouldn't put
- 4:29Speaker 1: my seal of guarantee that people aren't driving on oxy.
- 4:31Speaker 1: Cotton definitely are driving on it. I just think they're
- 4:34Speaker 1: less dangerous. Probably, So if you're a drunk driver switched
- 4:37Speaker 1: to oxy, we should just roll right into the scow. Wow,
- 4:41Speaker 1: I'm sweating and you're talking, don't break the law. I
- 4:47Speaker 1: heard that whisper. I'm raper. Oh wait, that was the intro.
- 4:51Speaker 1: I'm just gonna start reading the episode now. In the
- 4:54Speaker 1: early before World War One, Sophie and Isaac Sackler immigrated
- 4:58Speaker 1: to the United States from Poland and Ukraine, respectively. They
- 5:01Speaker 1: were both Jewish, which you may recall was not a
- 5:03Speaker 1: great thing to be in Poland or Ukraine around the
- 5:05Speaker 1: turn of the twentieth century or a couple of decades
- 5:08Speaker 1: after the turn of the twentieth century, or like pretty
- 5:11Speaker 1: pretty rough. Now. I don't want to sound ignorant, but
- 5:13Speaker 1: I didn't realize that early on it was bad. I
- 5:15Speaker 1: thought it was towards like the twenties. No, I mean
- 5:17Speaker 1: that it was bad. It was got worse than but
- 5:20Speaker 1: like you know, the late eighteen hundreds, the Zelnisky massacre,
- 5:23Speaker 1: which was like a bunch of Cossacks killing it might
- 5:26Speaker 1: have been as many as half a million Jewish people,
- 5:28Speaker 1: the biggest program in Russian history, and that I think
- 5:31Speaker 1: was pretty close to Ukraine. It might have been in
- 5:33Speaker 1: some of what is I don't know the exact geographical area,
- 5:35Speaker 1: but like, yeah, it was pretty rough. A lot of
- 5:37Speaker 1: bad stuff happening. Um And I don't know if the
- 5:40Speaker 1: Sacklers fled Eastern Europe because of, you know, a desire
- 5:45Speaker 1: not to get murdered, or because of crushing poverty, but
- 5:47Speaker 1: it was probably like a mix of the two. Um
- 5:49Speaker 1: So these refugees established themselves in New York City. Isaac
- 5:52Speaker 1: became a grocer. He and his wife had two children,
- 5:54Speaker 1: the eldest of which was Arthur. Arthur grew up to
- 5:57Speaker 1: become a psychiatrist. His specialty was something called biological psychiatry.
- 6:01Speaker 1: He was the very first physician in the world to
- 6:03Speaker 1: use ultrasound for a diagnosis. He was a major critic
- 6:06Speaker 1: of electro convulsive therapy and was a significant figure in
- 6:09Speaker 1: the racial integration of New York City's blood donation. So
- 6:12Speaker 1: it's pretty good so far. Kind of a critic of
- 6:14Speaker 1: the electrotherapy myself, so I've kind of them on his side.
- 6:19Speaker 1: I believe they still use it sometimes there's certain things
- 6:22Speaker 1: that it really does help, because I know some people
- 6:23Speaker 1: who have found it very helpful. But I've heard the
- 6:26Speaker 1: same thing. It's so hard for me to believe. It
- 6:28Speaker 1: seems so barbaric. I think the problem was they used
- 6:30Speaker 1: to do it for like everything, like, oh you looking
- 6:33Speaker 1: at guys, let's shocker skull, Like there's a couple of
- 6:36Speaker 1: things that really does help with and now they pretty
- 6:38Speaker 1: much only do it for those things. And I thought
- 6:40Speaker 1: the over diagnosis of a d D was a problem.
- 6:42Speaker 1: I guess we're I guess we're lucky. We're we're progressing. Yeah,
- 6:45Speaker 1: if they I mean, they just hit you back then,
- 6:47Speaker 1: were having a d D. And like the fifties, like
- 6:49Speaker 1: that was that was your riddle and it was getting
- 6:51Speaker 1: bunched better than the shock therapy. I think, I don't know.
- 6:53Speaker 1: Maybe depends on the hand fair enough. Yeah. Now, at
- 6:56Speaker 1: this point, the Sackler family seemed to be living the
- 6:59Speaker 1: epitome of the America can Dream. They'd gone from dirt
- 7:01Speaker 1: poor refugees, too well off, groundbreaking physicians in fifty years.
- 7:04Speaker 1: Pretty cool, I'm impressed. Pretty cool. But in nineteen fifty two,
- 7:08Speaker 1: Arthur made a fateful purchase that would decades later crippled
- 7:11Speaker 1: the United States and secure his family a place in
- 7:13Speaker 1: historical infamy for all time. He bought a company called
- 7:16Speaker 1: Perdue Frederick, a pharmaceutical drugmaker. Now Perdue Frederick had been
- 7:20Speaker 1: established in eighteen ninety two selling what we're called patent medicines,
- 7:24Speaker 1: essentially snakewi. Prior to Arthur's purchase, Produce Frederick's main product
- 7:27Speaker 1: had been Gray's Glycerin tonic, a broad application remedy sold
- 7:31Speaker 1: as a cure for basically everything. It was mostly wine.
- 7:35Speaker 1: It cures something like I've definitely had some things cured.
- 7:39Speaker 1: But when I have a nasty case of the sobriety,
- 7:42Speaker 1: I just break open a bottle of medicinal wine and
- 7:44Speaker 1: you know that's very very quickly. Yeah, yeah, very very fast.
- 7:49Speaker 1: Now Arthur put his brothers, Mortimer and Raymond in charge
- 7:51Speaker 1: of the company. Morty had been born in nineteen sixteen
- 7:54Speaker 1: and ray in nineteen twenty. Both brothers were also psychiatrist,
- 7:57Speaker 1: so the whole family goes into psychiatry, which you know,
- 8:00Speaker 1: good for the parents. Hyh even kids. Yeah, I mean
- 8:03Speaker 1: that's impressive. They're they're owning stores. I guess colleges were
- 8:06Speaker 1: different back then. I mean, how does all yeah like
- 8:10Speaker 1: yet you mowe a couple of lawns and you can
- 8:12Speaker 1: get your bachelor's back then. Oh man, yeah, yeah, it's
- 8:17Speaker 1: one of those things you look at, like even in
- 8:18Speaker 1: the seventies, you could work part time and pay off
- 8:21Speaker 1: college by the time you graduate. And it was like,
- 8:24Speaker 1: don't make me cry on on microphone right here. Now
- 8:27Speaker 1: it costs as much as two new trucks, and that's
- 8:31Speaker 1: not a great college. So all three kids were psychologists, psychiatrists,
- 8:36Speaker 1: they're able to like at that which makes sense, Perdue,
- 8:40Speaker 1: Perdue exactly. So Arthur put his brothers Mortimer, oh yeah,
- 8:44Speaker 1: he put them in charge of the company. So Arthur
- 8:46Speaker 1: was free to vote himself to what was increasingly his
- 8:48Speaker 1: passion marketing. I'm going to quote from a fantastic Esquire
- 8:52Speaker 1: article by Christopher Glazock. Quote Arthur intuitive that print ads
- 8:56Speaker 1: and medical journals could have a revolutionary effect on pharmaceutical sales.
- 8:59Speaker 1: Espec actually given the excitement surrounding the miracle drugs of
- 9:02Speaker 1: the nineteen fifties steroids, antibiotics, antihistamines, in psychotropics. In nineteen
- 9:06Speaker 1: fifty two, the same year that he and his brothers
- 9:08Speaker 1: acquired Perdue, Arthur became the first admin to convince the
- 9:11Speaker 1: Journal of the American Medical Association, one of the profession's
- 9:14Speaker 1: most of best publications, to include a color advertorial brochure.
- 9:19Speaker 1: So that's this guy's like, well, that's the fucking problem.
- 9:23Speaker 1: That's like, if you start marketing, if you start marketing drugs,
- 9:26Speaker 1: then that means you're spending money because you want to
- 9:28Speaker 1: make more money. And is that not the whole fucking sorry?
- 9:31Speaker 1: Are you? I don't know if there's a cursing on this.
- 9:33Speaker 1: There's plenty occurs, but it's just upsetting because that's the
- 9:36Speaker 1: root of the problem. It should never have been like, oh, marketings,
- 9:39Speaker 1: where we're going to really make our break. Your marketing
- 9:41Speaker 1: should be the doctor being like, you have this problem
- 9:44Speaker 1: in this medicine will help for That's the only marketing
- 9:46Speaker 1: drugs should have. You should be like, looking at color,
- 9:48Speaker 1: you have these spots all over your bodies, Well, how
- 9:51Speaker 1: about a measles vaccine? I need this? Yeah, yeah, exactly.
- 9:54Speaker 1: Like you know, nobody advertises like do you want polio?
- 9:57Speaker 1: Probably not, check out this new shot that'll take kid. No,
- 10:00Speaker 1: you should give people the polio effects. They don't get
- 10:03Speaker 1: sick now. Produced first big hit was Librium, which was
- 10:06Speaker 1: the first name Valium was marketed under. Arthur pitched Librium
- 10:10Speaker 1: as the key to treating psychic tension, a phrase he
- 10:12Speaker 1: invented because it sounded sexier than saying stress are They
- 10:15Speaker 1: suggested that psychic tension was the real cause of many maladies,
- 10:18Speaker 1: from heartburn to bad poops. The tactic worked like fucking gangbusters.
- 10:22Speaker 1: Valium became the most widely prescribed medication in the United States.
- 10:26Speaker 1: The first drug to break the one hundred million dollars
- 10:28Speaker 1: sales record. Arthur was quickly inducted into the Medical Advertising
- 10:31Speaker 1: Hall of Fame, a thing which should not exist. No,
- 10:34Speaker 1: I shouldn't know. Why why would you Why would you
- 10:37Speaker 1: be proud of that? Now, this might be outside of
- 10:39Speaker 1: your realm of thought. It was valium kind of the
- 10:42Speaker 1: trade off of what they used to do, lobotomies, Like,
- 10:44Speaker 1: wasn't it was? Is there? I don't. I think they
- 10:47Speaker 1: were still lobotomizing people the point, And this is like
- 10:50Speaker 1: the fifties, So if I'm not mistaken, this is when
- 10:52Speaker 1: um I think Rosemary Kennedy was her name, the JFK's
- 10:56Speaker 1: youngest sister, when they like scrambled her brains because she
- 10:59Speaker 1: liked boys. Um So I think they were still doing
- 11:02Speaker 1: that at this point. They were. But so it has
- 11:04Speaker 1: nothing because I thought that lobotomies and valium kind of
- 11:07Speaker 1: had a crossover. They might help been like it might
- 11:10Speaker 1: have Like, I just don't know that. I could see it.
- 11:13Speaker 1: I could see it helping with that. I've taken it
- 11:15Speaker 1: recreationally a couple of times when I was living in Guatemala.
- 11:18Speaker 1: You could just pick it up from the corner store.
- 11:20Speaker 1: So we would actually pick up valium and hide your
- 11:23Speaker 1: code own and it was like that was your that
- 11:26Speaker 1: was your like Thursday night or whatever it was. It
- 11:29Speaker 1: was fun. I meant this Irish biker who was like
- 11:31Speaker 1: traveling biking all the continents. Now, when you say biker,
- 11:35Speaker 1: I need to know the difference. Is it peddling biker
- 11:37Speaker 1: or motorcycle huge fucking motorcycles. Yeah, sure, he just he
- 11:42Speaker 1: spent like three weeks just doing all of the valume.
- 11:44Speaker 1: I've never seen anyone two more values. He's crushing it
- 11:47Speaker 1: up in railing three at a time. Yeah, that's just
- 11:50Speaker 1: never been my party truck. No, I'm not a huge
- 11:53Speaker 1: fan of it um, but yeah, it's sold very well
- 11:56Speaker 1: for for Arthur Sackling. So it was Arthur who began
- 11:59Speaker 1: the Sackler family tradition of donating huge sums of money
- 12:02Speaker 1: to museums. Some of this may have been honest generosity,
- 12:04Speaker 1: but a lot of it was also a tax thing.
- 12:06Speaker 1: When he created the Sackler Gallery at the Metropolitan Museum
- 12:09Speaker 1: of Art, he gave it a huge collection of Chinese artifacts,
- 12:12Speaker 1: but he required the museum to sell him the artifacts.
- 12:14Speaker 1: He was giving them for a very low price. What
- 12:17Speaker 1: he paid originally in the nineteen twenties when he'd acquired them,
- 12:19Speaker 1: so he could then donate the artifacts back to the
- 12:22Speaker 1: museum but write them off at their nineteen sixties value,
- 12:25Speaker 1: so that he made net money donating these things to
- 12:28Speaker 1: the museum. It sounds like a scam. It's definitely the
- 12:32Speaker 1: only reason it's not a scam. It's because he has
- 12:34Speaker 1: enough lawyers to sue you for calling it. Oh, that's true.
- 12:36Speaker 1: It sounds like the art version of a shell company.
- 12:39Speaker 1: It's absolutely that, Like it's legally distinct from a scam
- 12:43Speaker 1: because he can afford to pay lawyers. Like, yeah, exactly,
- 12:47Speaker 1: but it's it's the same thing as like that guy
- 12:49Speaker 1: on the street corner putting like a dot or whatever
- 12:52Speaker 1: underneath a bunch of cups and ask you get a
- 12:54Speaker 1: bet on which, like it's it's a con for sure. Now,
- 12:57Speaker 1: Jillian Sackler, Arthur's third wife, does call this allegation fake news,
- 13:01Speaker 1: So that should tell you when that was recently to say,
- 13:05Speaker 1: that's a very new term. Yeah, yeah, yeah, that was. Yeah.
- 13:09Speaker 1: He had to re up a couple of times. Yeah,
- 13:11Speaker 1: I think they all did. In general, the Sackler brothers
- 13:14Speaker 1: seemed to have been the kind of rich people I
- 13:16Speaker 1: would not have gotten along with. Mortimer threw a fit
- 13:18Speaker 1: on his seventy birthday when the met agreed to let
- 13:20Speaker 1: him throw his birthday party there, but they wouldn't let
- 13:23Speaker 1: him redecorate an ancient shrine that he wanted as the
- 13:25Speaker 1: centerpiece to his party. So he got very angry at them,
- 13:28Speaker 1: like that's the attitude this family has. So that said,
- 13:31Speaker 1: there was nothing super evil about this generation of the Sacklers.
- 13:34Speaker 1: They were questionable, Okay, go ahead, yeah, yeah there was. Yeah,
- 13:37Speaker 1: they were questionable, but they weren't like mustache twirling villains.
- 13:40Speaker 1: They also weren't that rich by rich people standards. They
- 13:42Speaker 1: were multimillionaires, but not billionaires or multibillionaires. Raymond and Mortimer
- 13:47Speaker 1: had paid attention to their brother's success with valium. They
- 13:50Speaker 1: realized that if you could just take a powerfully addictive
- 13:52Speaker 1: substance and then marketed as a cure all for a
- 13:54Speaker 1: bunch of different things, well that was incredibly profitable. So
- 13:56Speaker 1: they started looking for another drug that they could basically
- 13:59Speaker 1: apply the valiums ategy too. In nineteen seventy two, a
- 14:02Speaker 1: London doctor had developed a special slow release medicine technology.
- 14:05Speaker 1: In nineteen eighty one, MS content entered the UK market,
- 14:09Speaker 1: was a timed release morphine pill designed to hopefully be
- 14:12Speaker 1: less addictive than traditional morphine. In nine seven, Produce Pharmaceutical
- 14:16Speaker 1: brought MS content to the US market. Now the drug
- 14:19Speaker 1: was a big hit for cancer patients, and Perdue made
- 14:21Speaker 1: a tidy sum helping suffering sick people into their mortal illnesses.
- 14:26Speaker 1: Whenever I hear something, I gotta ask them a questioner.
- 14:29Speaker 1: So when they think it's gonna be less addictive, to
- 14:31Speaker 1: think it's going to be less addictive because it's something
- 14:33Speaker 1: that is not creating a habitual use, because it's slow release.
- 14:37Speaker 1: That's exactly like, it's not like they're One of the
- 14:39Speaker 1: big things you're trying to avoid is the euphoria, because
- 14:41Speaker 1: like taking pain killers, it gives you this like feeling
- 14:43Speaker 1: of euphoria when you first come up, and that's one
- 14:45Speaker 1: of the things it's most addictive about it. So the
- 14:47Speaker 1: idea was that if it's slow release, people won't get
- 14:50Speaker 1: hooked as easily. It will be less pleasurable, but it
- 14:52Speaker 1: will fight pain more effectively. So number one, you'll have
- 14:55Speaker 1: to take fewer pills um and number two, you're less
- 14:58Speaker 1: likely to develop a habit just like show someone up
- 15:00Speaker 1: with heroin, you know, like one of the There was
- 15:02Speaker 1: a big stigma against opiates at this point in the
- 15:06Speaker 1: United States and like the seventies and eighties because a
- 15:08Speaker 1: bunch of young men had been given morphine basically UM
- 15:11Speaker 1: in Vietnam, Like they get shot and they get shot
- 15:13Speaker 1: up with morphine and then they wound up horribly addicted
- 15:16Speaker 1: to morphine and so like, there was a real stigma
- 15:18Speaker 1: against taking any kind of opiate pain killer in the
- 15:20Speaker 1: US for like during this period. So MS content was
- 15:24Speaker 1: really only used by cancer patients, Like it was the
- 15:27Speaker 1: only people who would get prescribed in this kind of
- 15:29Speaker 1: medicine where people who were like dying essentially um. So,
- 15:33Speaker 1: you know, Purdue made a decent amount of money off
- 15:35Speaker 1: of it, but it was impossible to make a lot
- 15:37Speaker 1: of money off of it because it wasn't being prescribed
- 15:39Speaker 1: for anything but mortal illnesses. MS content was unlikely to
- 15:42Speaker 1: ever become a valium level seller, and that was a
- 15:45Speaker 1: problem for Purdue Pharmaceuticals, fortunately for the Sackler family and
- 15:49Speaker 1: unfortunately for the entirety of rural America. In nine six,
- 15:52Speaker 1: two doctors published an article in a medical journal that suggested,
- 15:55Speaker 1: based on a thirty eight patient study that long term
- 15:58Speaker 1: opiate use was safe for patients out a history of
- 16:00Speaker 1: drug abuse. This, combined with a widespread, completely fallacious belief
- 16:04Speaker 1: that the rate of addiction for long term opiate use
- 16:07Speaker 1: was less than one percent, helped convince the leadership at
- 16:09Speaker 1: Purdue that opiates for the future of their company. It
- 16:13Speaker 1: was a future Arthur Sackler would not live to see.
- 16:15Speaker 1: He died in nineteen eighties seven. His last words to
- 16:17Speaker 1: his family were reportedly, leave the world a better place
- 16:21Speaker 1: than when you entered it. Those are great words of wisdom,
- 16:24Speaker 1: great words of wisdom. You know it, you hear about
- 16:26Speaker 1: His family didn't do any of that. From this point on.
- 16:32Speaker 1: Richard Sackler, Raymond's son and Arthur's nephew, would grow to
- 16:35Speaker 1: become the head of the family and eventually the company.
- 16:37Speaker 1: Here's how Esquire described him quote, perhaps the most private
- 16:40Speaker 1: member of a generally secretive family. Richard appears nowhere on
- 16:42Speaker 1: produced website from public records and conversations with former employees,
- 16:45Speaker 1: though a rough portrait emerges of a testy, eccentric with
- 16:48Speaker 1: ardent relentless ambitions. Born in nineteen forty five, he holds
- 16:51Speaker 1: degrees from Columbia University and n y U Medical School,
- 16:54Speaker 1: according to a bio on the website of the Coke
- 16:56Speaker 1: Institute for Integrative Cancer Research at m i T, where
- 16:59Speaker 1: Richard serves on the advisory board. He started working at
- 17:01Speaker 1: Perdue as his father's assistant at age twenty six, before
- 17:04Speaker 1: eventually leading the firm's R and D division and separately
- 17:07Speaker 1: it's sales and marketing division. So like Arthur, he's not
- 17:10Speaker 1: just a doctor who likes research. He's really into marketing
- 17:13Speaker 1: and advertisement. Maybe he should have just done that, like
- 17:17Speaker 1: she could have been making ads. And there's a lot
- 17:19Speaker 1: of money in advertisement. Yeah, I mean, he makes a
- 17:21Speaker 1: lot of money in advertisement. It's just forty it's not
- 17:26Speaker 1: the thing you want to advertise it now. Raymond took
- 17:29Speaker 1: a step back during this period, presumably to allow his
- 17:31Speaker 1: son to shine. One of Richard's colleagues during this time,
- 17:34Speaker 1: who lived through the transition, recalled that the new boss
- 17:36Speaker 1: brought a new intensity to the job. Richard really wanted
- 17:39Speaker 1: Perdue to be big, I mean really big. The best
- 17:42Speaker 1: opportunity for that was, of course, a new drug based
- 17:45Speaker 1: on the content system. The patent for m S content
- 17:47Speaker 1: was about to run out but produce. Scientists were developing
- 17:49Speaker 1: a similar drug, basically a time release version of an
- 17:52Speaker 1: old opiate called oxycodon. Now in the nineteen thirties, oxycodon's
- 17:57Speaker 1: most popular formation was scope at all, a mix of
- 17:59Speaker 1: ox e cod own, scope, lamine, and aphedron. Was basically
- 18:02Speaker 1: an early speedball. The Wehrmacht loved it. It It was like
- 18:06Speaker 1: one of the most popular Nazi drugs of the whole
- 18:07Speaker 1: Nazi era. During Operation to Himmler, when the German staged
- 18:10Speaker 1: a false flag attack on themselves to justify the invasion
- 18:13Speaker 1: of Poland, the prisoners they dressed as Polish soldiers were
- 18:16Speaker 1: all killed via massive injections of Scope at all. So
- 18:18Speaker 1: oxycodone as a fun history before it became oxy content,
- 18:22Speaker 1: and Perdue was about to add a new chapter to
- 18:24Speaker 1: that history. Esquire talked to Peter Lacoutree uh, a senior
- 18:28Speaker 1: director of clinical research at Perdue from two thousand one,
- 18:31Speaker 1: and he explained how the idea evolved. At all the meetings.
- 18:34Speaker 1: That was a constant source of discussion. What else can
- 18:36Speaker 1: we use the content system for? And that's where Richard
- 18:38Speaker 1: would fire some ideas, maybe antibiotics, maybe chemotherapy. He was
- 18:41Speaker 1: always out there digging. So Sally Allen, a former executive
- 18:45Speaker 1: director for Product Management, added that Richard was very interested
- 18:48Speaker 1: in the commercial side and also very interested in marketing approaches.
- 18:51Speaker 1: He didn't always wait for the research results. So by
- 18:54Speaker 1: nine there was ample evidence that MS content had a
- 18:56Speaker 1: dangerous potential for abuse. It had already become one of
- 18:59Speaker 1: the most used prescription opioids in the United States, but that,
- 19:03Speaker 1: of course did not make Richard any less likely to
- 19:06Speaker 1: think it was a good product to market. You know,
- 19:08Speaker 1: they kind of ignored the fact that there were already
- 19:10Speaker 1: signs that time release morphine was no less addictive than
- 19:14Speaker 1: regular morphine and just sort of made time release oxycodon't
- 19:18Speaker 1: assumed it would work. Wouldn't the world be a better
- 19:20Speaker 1: place if they were, like, we really should do time
- 19:22Speaker 1: released antibiotics. Yeah, yeah, yeah, they decided not to do. No.
- 19:27Speaker 1: I mean, I think they probably made those at some
- 19:28Speaker 1: point too, But antibiotics. Nobody's gonna want to take a
- 19:31Speaker 1: shipload of antibiotics. What about with the right advertising, You
- 19:34Speaker 1: don't think with the right pitch, don't you won't die? Yeah?
- 19:38Speaker 1: I don't even sure how you advertise that stuff. Yeah,
- 19:41Speaker 1: I guess you're right, yeah, oxyconton You just have a
- 19:43Speaker 1: picture of some guy sitting out at like a beach
- 19:44Speaker 1: and looks like he's an old guy surgery scar in
- 19:49Speaker 1: his arm, but he's smiling, and it's just like freedom. Oxycontent. Yeah,
- 19:54Speaker 1: it's kind of good name too. I hate to say it,
- 19:56Speaker 1: but it's an exciting name to just say. Yeah, and
- 19:58Speaker 1: it's got one of those names that sure it's well
- 20:00Speaker 1: to a street drug. You got any oxy bro like
- 20:02Speaker 1: you know? MS content like you? No one's gonna be
- 20:04Speaker 1: like you got any MS content, I guess, but yeah, anyway,
- 20:08Speaker 1: we're gonna find out what happens next with Richard Sackler,
- 20:11Speaker 1: the other Sacklers and Oxycontent. But first some ads for
- 20:15Speaker 1: products that hopefully aren't produced pharmaceuticals that that that might be.
- 20:19Speaker 1: There's there's no knowing. It's randomly slotted in, so uh
- 20:24Speaker 1: hopefully not. We're back so Due Pharmaceutical convened a series
- 20:36Speaker 1: of focus groups with physicians trying to decide if they'd
- 20:39Speaker 1: be willing to prescribe oxycontent, the company's new drug for
- 20:42Speaker 1: non cancer pain. Most doctors were unwilling to do this.
- 20:45Speaker 1: They worried about getting their patients horribly addicted. To a
- 20:47Speaker 1: dangerous drug and perhaps igniting an opioid epidemic. Pretty learned
- 20:50Speaker 1: that physicians did want a long lasting pain reliever that
- 20:52Speaker 1: was less addictive than morphineous, considered kind of like the
- 20:54Speaker 1: holy grail of medicine at that point. Now they didn't
- 20:57Speaker 1: have such a drug. Oxycontent was just as it active
- 21:00Speaker 1: as the old bills, perhaps even more addictive. But the
- 21:02Speaker 1: focus groups taught them that there was an incredible potential
- 21:04Speaker 1: in selling such a product, whether or not they actually
- 21:07Speaker 1: had one. Pharmaceutical released oxycontent onto the open market that
- 21:12Speaker 1: the company launch party for the new drug, Richard Sackler
- 21:14Speaker 1: compared the launch of oxycontent to a natural disaster, asking
- 21:17Speaker 1: the audience to imagine a blizzard or a hurricane, and saying,
- 21:20Speaker 1: the launch of oxycontent tablets will be followed by a
- 21:22Speaker 1: blizzard of prescriptions that will bury the competition. The prescription
- 21:25Speaker 1: blizzard will be so deep, dense and white. Oh wow, Richard, No,
- 21:31Speaker 1: don't like you know what you're doing. Like he must
- 21:36Speaker 1: have suspected it sounds it sounds like he was thinking
- 21:39Speaker 1: money was more important than people. It sounds like that
- 21:42Speaker 1: might have been his only motivating factor. Yeah, the predecessor
- 21:46Speaker 1: drug MS content had a reputation from being very prone
- 21:48Speaker 1: to abuse. Many patients had figured out how to crush
- 21:50Speaker 1: it and extract pure oxy code on, thus getting past
- 21:53Speaker 1: that nasty time release thing and giving them a much
- 21:55Speaker 1: more addictive drub. So PERTTU instructed at sales staff to
- 21:57Speaker 1: light to doctors and say that this could not be
- 21:59Speaker 1: done oxy content, even though their own internal studies showed
- 22:02Speaker 1: that it was actually super easy to do with oxy content. Well,
- 22:05Speaker 1: I mean, I might be wrong. I grew up in
- 22:08Speaker 1: the nineties, But was it a new invention crushing pills,
- 22:11Speaker 1: because that's always been like, oh, you want to just
- 22:13Speaker 1: crush it up? They they didn't think that was part
- 22:15Speaker 1: of well they did abuse strategy. They did. They knew
- 22:18Speaker 1: it could be done. They done studies showing that it
- 22:21Speaker 1: was really easy to extract pureoxy code on from oxycontent.
- 22:23Speaker 1: They just lied to doctors and said it couldn't be done,
- 22:26Speaker 1: like trick, you know exactly. It was like, it's really
- 22:29Speaker 1: hard to make a pill people can't crush and then
- 22:31Speaker 1: purifying store, Why don't we just lie? This pill is
- 22:35Speaker 1: fortified with iron? Who can bend iron? Superman, Superman? This
- 22:40Speaker 1: pills they have like one trial pill that's just made
- 22:43Speaker 1: out of steel, and they're like, look, you can't crush it.
- 22:46Speaker 1: Don't try the others. Don't try the other not now.
- 22:52Speaker 1: As a pending Massachusetts lawsuit against the company alleges quote
- 22:55Speaker 1: doctors had the crucial misconception that oxycontent was weaker than morphine,
- 22:59Speaker 1: which led them to pursue iboxy content much more often.
- 23:02Speaker 1: Michael Colon, a Pretty executive, wrote this letter to Richard Sackler.
- 23:06Speaker 1: Since oxycodone is perceived as being weaker a weaker opioid
- 23:09Speaker 1: than morphine, it has results of oxy contin being used
- 23:12Speaker 1: much earlier for non cancer pain. Physicians are positioning this
- 23:15Speaker 1: product where perkose at hydrocdone and tailan al with codeine
- 23:17Speaker 1: have traditionally been used. It is important that we be
- 23:20Speaker 1: careful not to change the perception of physicians towards oxycodone
- 23:23Speaker 1: when developing promotional pieces, symposia, review studies, articles, etcetera. Sackler's
- 23:28Speaker 1: response to this was short and sweet. I think that
- 23:30Speaker 1: you have this issue well in hand. Again, they think
- 23:33Speaker 1: it's not addictive. Don't tell them the truth. Yeah, they
- 23:37Speaker 1: know what they're doing. That same year, Michael Friedman, the
- 23:40Speaker 1: company head of sales, emailed his boss with similar concerns.
- 23:42Speaker 1: Correcting the false impression that doctors had about oxy would
- 23:45Speaker 1: be bad for business. Quote, it would be extremely dangerous
- 23:48Speaker 1: at this early stage in the life of the product
- 23:50Speaker 1: to make physicians think the drug is stronger or equal
- 23:52Speaker 1: to morphine. We are well aware of the view held
- 23:54Speaker 1: by many physicians that oxycodon is weaker than morphine. I
- 23:57Speaker 1: do not plan to do anything about it. Again, Richard's
- 24:00Speaker 1: actually replied, I agree with you. He then asked, is
- 24:03Speaker 1: there a general agreement or are there some holdouts? Everybody
- 24:05Speaker 1: on board about lieing to doctors. We all in the
- 24:08Speaker 1: same the same boat here. Yeah, it's it's it's pretty
- 24:11Speaker 1: blatant criming. I mean, and there's a paper trail for this.
- 24:14Speaker 1: It seems like like thousands of emails. And it's unless
- 24:18Speaker 1: I'm wrong, they're still selling oxyconton today, right, Oh, I
- 24:22Speaker 1: mean yeah, I mean unless it was this morning that
- 24:24Speaker 1: there was a breaking news I missed. You're not gonna
- 24:26Speaker 1: stop selling and this is all like that. You don't
- 24:28Speaker 1: have exclusive access to this information. No, no, no, no no.
- 24:32Speaker 1: There's been a number of big stories. We'll get to
- 24:34Speaker 1: that in a little bit. How this all came out. Sorry, sorry, no,
- 24:37Speaker 1: it's all good. Now. All this was to volage of
- 24:39Speaker 1: the result of a lawsuit followed by the state of
- 24:41Speaker 1: Kentucky against Perdue in two thousand fifteen. As you'd expect,
- 24:45Speaker 1: the company had already explanationist what Sackler and his executives
- 24:48Speaker 1: did was not fraud. Here's pro publica quote Sackler, it said,
- 24:52Speaker 1: supports that the company accurately discloses the potency of oxycontent
- 24:55Speaker 1: to healthcare providers. He takes great care to explain that
- 24:57Speaker 1: the drugs label made it clear that oxycontent is to
- 25:00Speaker 1: wise is potent as morphine produced set Still, Perdu acknowledged
- 25:03Speaker 1: it had made a determination to avoid emphasizing oxycontent as
- 25:06Speaker 1: a powerful cancer pain drug out of a concern that
- 25:09Speaker 1: non cancer patients would be reluctant to take a cancer drug.
- 25:13Speaker 1: So we, in light of doctors, we just didn't emphasize
- 25:16Speaker 1: the truth so that people would keep taking the pills.
- 25:19Speaker 1: Since that's different from a lie. Yeah, it's a it's
- 25:22Speaker 1: not really that different. It's it's not really it's kind
- 25:24Speaker 1: of just a lie. It's it's a lie. Yeah, it's
- 25:26Speaker 1: kind of just a lie. No documents released from the
- 25:28Speaker 1: Kentucky suit as well as a lawsuit in Massachusetts paint
- 25:31Speaker 1: a picture that puts Richard Sackler square in the middle
- 25:33Speaker 1: of produced strategy to silly shipload of oxycontent by lying
- 25:35Speaker 1: about how strong it was. Seven other Sackler family members
- 25:38Speaker 1: were also implicated. The strategy worked like gangbusters, ending the
- 25:41Speaker 1: company forty eight million dollars in the first full year
- 25:44Speaker 1: of sales. In an email to the company, Richard noted, clearly,
- 25:47Speaker 1: this strategy has outperformed our expectations, market research, and fondest dreams.
- 25:51Speaker 1: So forty eight million dollars. This is back in the nineties.
- 25:53Speaker 1: This is I think. Yeah, that's the first year. Three
- 25:57Speaker 1: years later, after tens of millions more in sale. He
- 26:00Speaker 1: emailed this to an executive a perdue quote. You won't
- 26:02Speaker 1: believe how committed I am to make OxyContin a huge success.
- 26:05Speaker 1: It is almost that I dedicated my life to it.
- 26:07Speaker 1: After the initial launce phase, I will have to catch
- 26:09Speaker 1: up with my private life again. Just working too hard.
- 26:12Speaker 1: Line to doctors, poor guy, it sounds like he's got
- 26:15Speaker 1: psychic stress or psychic You should try try some liberal here.
- 26:19Speaker 1: It's great for psychic stress. It's so liberating. It's liberating.
- 26:23Speaker 1: It wasn't psychic stress. What's it called psychic I think
- 26:26Speaker 1: that was the word psychic stress. Yeah, I think that
- 26:28Speaker 1: was the term he used. Yeah. Now, when he was
- 26:30Speaker 1: deposed to Massachusetts, Richard Sackler denied that he had participated
- 26:33Speaker 1: in any kind of gigantic lie to trick doctors and
- 26:35Speaker 1: over prescribing oxycontent. According to pro Publica, he quote offered
- 26:39Speaker 1: benign interpretations of emails that appeared to show perdue executives
- 26:43Speaker 1: or sales representatives minimizing the risks of OxyContin and its
- 26:46Speaker 1: euphoric effects. He denied that there was any effort to
- 26:48Speaker 1: deceive doctors about the potency of oxycontent, and argued that
- 26:51Speaker 1: lawyers for Kentucky were misconstruing words such as stronger and
- 26:54Speaker 1: weaker used in email threads. The term stronger in Freedman's email,
- 26:58Speaker 1: Sackler said, meant more threating, more frightening. There is no
- 27:01Speaker 1: way that this intended or had the effect of causing
- 27:03Speaker 1: physicians to overlook the fact that it was twice as potent.
- 27:07Speaker 1: We went saying it's not stronger. We're saying it's not
- 27:09Speaker 1: more threatening than morphine. It's just a little pill. It's
- 27:12Speaker 1: not scary. Morphine comes in a needle. Sometimes that's scary. Well,
- 27:16Speaker 1: I guess, I mean, I am not defending them already,
- 27:19Speaker 1: think that a bunch of ship backs. But honestly, there
- 27:22Speaker 1: should be more questions about this. Why did they not ask? Okay,
- 27:25Speaker 1: strength is one thing. The potency seems like a very
- 27:28Speaker 1: scientific question to ask. Yeah, I mean it does. It's
- 27:31Speaker 1: it seems like a lot of doctors fell down on
- 27:33Speaker 1: the job here. We'll get into y in a little bit,
- 27:36Speaker 1: because they they they they there's some doctors being shady
- 27:39Speaker 1: as fucking this in this story too. Actually quite a
- 27:42Speaker 1: lot of not surprising at all, not surprising at all.
- 27:45Speaker 1: Hey man, you got a lot of fucking student loans
- 27:47Speaker 1: to pay back. I get that m D Like if
- 27:49Speaker 1: you write some pill prescriptions, that makes that sh it easier.
- 27:52Speaker 1: It's like all those doctors in l A, you rememberhen
- 27:54Speaker 1: it like medical marijuana was like the thing, and there
- 27:56Speaker 1: would be all those like old doctors who was just
- 27:58Speaker 1: like signing pop your scripture retirement plan. Yeah. That was
- 28:02Speaker 1: for a long time before Obamacare. My only doctor that
- 28:05Speaker 1: was one doctor appointment. I get the only doctor scary
- 28:09Speaker 1: when he'd give me advice of like, oh it's pretty high,
- 28:12Speaker 1: Oh my god, the pot doctor wants me to cool off.
- 28:14Speaker 1: When the pot doctor gives you real medical advice, should
- 28:18Speaker 1: go see someone like, no way, you're scaring me, sir.
- 28:21Speaker 1: I remember my first pot doctor. It was near Venice Beach,
- 28:24Speaker 1: and I like walk into this shady, dirty office and
- 28:27Speaker 1: there's like, as I'm standing outside his office, there's a
- 28:30Speaker 1: poster of it's like a fake painting of the Mona Lisa,
- 28:33Speaker 1: but she's got a blunt and like, and then I
- 28:35Speaker 1: go to the office and the guy's wearing a lab
- 28:37Speaker 1: coat and I'm like, dude, you don't you don't need
- 28:39Speaker 1: to buy a lab coat. You got them from the
- 28:41Speaker 1: costume shot. I think we went to is it was.
- 28:45Speaker 1: He a really old guy with accent, very thick accent.
- 28:49Speaker 1: I think that he was a hot doctor back in
- 28:52Speaker 1: the I don't know what he's doing today. I hope
- 28:54Speaker 1: he made enough to retire, because he should not be
- 28:56Speaker 1: practicing medicine. I'm just crossing my fingers. There's never an
- 28:59Speaker 1: EP episode two about him. And Behind the Bastards. I mean, yeah,
- 29:03Speaker 1: I don't even remember that guy's name, but I'm sure
- 29:05Speaker 1: he did something terrible but wind up being a pot doctor.
- 29:08Speaker 1: I guess so so produced bald face lying to patients
- 29:11Speaker 1: and doctors was enabled by the f D. A. Curtis Right,
- 29:14Speaker 1: the FDA examiner who approved Oxycontin's initial application, allowed the
- 29:17Speaker 1: company to include this note on the package. The late
- 29:21Speaker 1: absorption is provided by oxyconton tablets is believed to reduce
- 29:24Speaker 1: the abuse liability of a drug. Wow, that word believed.
- 29:29Speaker 1: That word is doing a lot of weightlifting there carrying
- 29:33Speaker 1: the others. Really, I mean, I'm a critical thinker, but
- 29:35Speaker 1: when I see a word like believe, the first thing
- 29:37Speaker 1: I do is stop believing and start like looking things up. Yeah,
- 29:41Speaker 1: looking things up, seeing maybe believe. There's nine times out
- 29:46Speaker 1: of ten clue that you shouldn't. You don't want to
- 29:49Speaker 1: hear that from a doctor like you have. We believe
- 29:50Speaker 1: this will help, Like, oh, I feel like you should
- 29:53Speaker 1: know a little better. I mean, I know a medicine
- 29:57Speaker 1: sometimes it's a crapshoot, but it's not not comfort to
- 30:00Speaker 1: hear that. In the year after oxy Content's release, Curtis
- 30:04Speaker 1: Right quit the f DA. He was hired by another
- 30:06Speaker 1: pharmaceutical company for a short while, and then hired by
- 30:08Speaker 1: Perdue Pharmaceuticals. Esquire talked to him years later, and he
- 30:11Speaker 1: offered this defense quote. At the time, it was believed
- 30:14Speaker 1: that extended release formulations were intrinsically less abusable. It came
- 30:18Speaker 1: as rather a big shock to everybody, the government and
- 30:20Speaker 1: Purdue that people found ways to grind up, chew up, snort,
- 30:23Speaker 1: dissolve and in check the pills. We didn't we know
- 30:26Speaker 1: people would do the thing that they do with every drug,
- 30:29Speaker 1: like every every single drug. It's like, of course they
- 30:32Speaker 1: predicted people would be booping and putting it in their
- 30:34Speaker 1: crushing the crushing. God, where did they think. We'd never
- 30:39Speaker 1: heard of this drug we made in the eighties, We
- 30:40Speaker 1: had never heard of people railing drugs. Who would I
- 30:44Speaker 1: guess that? Come on, come on, dude, I mean people
- 30:49Speaker 1: are going to find a way to get high off
- 30:50Speaker 1: of a drug like this is this is people we're
- 30:53Speaker 1: talking about. You can get high on holding your breath. Yeah,
- 30:55Speaker 1: you can get and we do. Oh boy. Like I'm
- 30:59Speaker 1: sure after that video of the dolphins passing pupper fish
- 31:02Speaker 1: around went viral, there's people that are trying to figure out.
- 31:06Speaker 1: But I haven't seen it yet. I think you're going
- 31:08Speaker 1: to have like a scuba club that all dies. I
- 31:11Speaker 1: want to do it, but could I get high on
- 31:13Speaker 1: puffer fish. I don't know. You know, I know a guy.
- 31:15Speaker 1: He's a dolphin, but I know a dolphin. Okay, we'll
- 31:19Speaker 1: talk after him, we'll talk afterwards. I don't want to.
- 31:21Speaker 1: I don't want to get the d a on my
- 31:23Speaker 1: asked for selling dolphin drugs. Uh. Yeah. So a major
- 31:28Speaker 1: part of oxycoton success was produced novel strategy of declaring
- 31:31Speaker 1: a war on pain. Over the course of late nineteen nineties,
- 31:34Speaker 1: they poured millions and millions of dollars into backing doctors
- 31:37Speaker 1: who supported opioid treatment for chronic pain. These doctors formed
- 31:40Speaker 1: advocacy groups like the American Pain Society, the American Academy
- 31:44Speaker 1: of Pain Medicine, and produce own lobbying organization Partners against Pain,
- 31:49Speaker 1: Partners You Me and this Crippling pill Addiction Partners against Pain.
- 31:54Speaker 1: Did they really call it a war on pain? Yeah?
- 31:56Speaker 1: And that was again I'm not great at history, but
- 31:59Speaker 1: that's the same time the war on drugs was going on. Yeah.
- 32:02Speaker 1: That's like a gorilla like like clandescent war that we
- 32:05Speaker 1: were running. Yeah. Yeah, it's it's like it's like the
- 32:08Speaker 1: war in Nicaragua where Yeah, so that's kind of similar.
- 32:12Speaker 1: If we have a war on drugs and a war
- 32:13Speaker 1: on pain using oxycon using oxyconton, which is different from
- 32:17Speaker 1: a drug for reasons. It's supplying arms to the talent band. Okay,
- 32:22Speaker 1: that's that's a different story, but it would be. It's
- 32:25Speaker 1: like when we sold missiles to Iran while giving missiles
- 32:29Speaker 1: to Iraq to fight Iran. That's it's the v of drugs.
- 32:32Speaker 1: That's the lines I'm making. Yeah, yeah, yeah. These groups,
- 32:36Speaker 1: which many consider to just be fronts for big pharma
- 32:39Speaker 1: operated by crooked doctors, pushed regulators to treat pain like
- 32:42Speaker 1: the fifth vital sign. They advocated for a ten point
- 32:45Speaker 1: pain scale, which doctors should ask patients about during every visit.
- 32:48Speaker 1: An internal produced strategy document explained that the goal of
- 32:51Speaker 1: this was to quote attach an emotional aspect to non
- 32:53Speaker 1: cancer pain. This would hopefully cause doctors to treat it
- 32:57Speaker 1: more seriously and aggressively a k A with a C content. Now,
- 33:01Speaker 1: until that point, pain had, to a certain extent, been
- 33:03Speaker 1: something chronic suffers just dealt with. Uh. There were obviously
- 33:07Speaker 1: attempts to mitigate it as best as possible, but complete
- 33:09Speaker 1: cessation of pain was seen as simply unrealistic and the
- 33:12Speaker 1: risk of giving chronic pain sufferers, morphine was considered too high.
- 33:16Speaker 1: With OxyContin produce changed all that. The ironic thing is
- 33:19Speaker 1: it wasn't actually super effective against chronic pain. It was
- 33:22Speaker 1: marked as lasting twelve hours, so patients could sleep through
- 33:25Speaker 1: a night free of agony, but most patients only got
- 33:27Speaker 1: about six to eight hours of relief. This meant they
- 33:29Speaker 1: took more oxycontent, which meant they ran through their prescriptions faster,
- 33:32Speaker 1: which led them to calling doctors in agony. When doctor's
- 33:35Speaker 1: questions sales reps about this cycle, Perdue advised them to
- 33:38Speaker 1: increase the dose rather than the dosing frequency, which guaranteed
- 33:41Speaker 1: that the cycle would keep on keeping on and also
- 33:43Speaker 1: increased produce profits. Now, doctors aren't dumb, and many of
- 33:47Speaker 1: them were hesitant about some of the claims Perdue was making.
- 33:49Speaker 1: They were particularly considering a moment now when when I
- 33:54Speaker 1: like everything with oxycotton right now, I understand that's its
- 33:57Speaker 1: own beast, But the whole one to ten scale of pain,
- 34:00Speaker 1: I'm a little confused and how authentic that is? Is
- 34:03Speaker 1: that really a scientific method? Because I've heard that before,
- 34:05Speaker 1: But what's to stop somebody? And I'm not telling anyone
- 34:09Speaker 1: that their pain is not the number, they say, yea,
- 34:11Speaker 1: but what's to stop someone from saying their pain is
- 34:13Speaker 1: something higher than it is nothing? Okay, I just want
- 34:16Speaker 1: to make sure that there wasn't something I was missing. No,
- 34:18Speaker 1: there's no way to, like, you can't there's not like
- 34:22Speaker 1: an objective measurement of pain, Like you know, I know
- 34:25Speaker 1: people who have chronic pain conditions, for whom like you know,
- 34:29Speaker 1: they'll get hurt like in a way that would like
- 34:32Speaker 1: fuck me up for a day or two, and they
- 34:34Speaker 1: just like sort of grin and bear it because they're
- 34:35Speaker 1: so used to dealing with pain. So yeah, like there's
- 34:38Speaker 1: no way to objectively measure pain. And I'm not saying
- 34:41Speaker 1: like a tin point pain scale is necessarily a bad idea,
- 34:44Speaker 1: but Purdue introduced it specifically so that because it would
- 34:48Speaker 1: make it easier for people to get prescribed introduced. Ye
- 34:51Speaker 1: I didn't realize that it was doctors and stuff that
- 34:55Speaker 1: they were fun that they were like it was it
- 34:57Speaker 1: was a thing there. I know, the marionette man controls
- 34:59Speaker 1: all the puppets exactly, a fool. They were like, if
- 35:02Speaker 1: we have this, if this is the way people do
- 35:04Speaker 1: this stuff, it'll be a lot easier to sell a
- 35:05Speaker 1: shipload of Oxyconton, and it was speaking of selling a
- 35:09Speaker 1: shipload of things that aren't oxyconton unless the ad that
- 35:13Speaker 1: gets randomly slotted in is for oxycon. God, I hope not.
- 35:16Speaker 1: It might be. There's no way to know. We've been
- 35:18Speaker 1: having Koke Brothers ads. You know, I'm sure a Blackwater
- 35:22Speaker 1: ad will wind up soon. Like the Koke Brothers are
- 35:24Speaker 1: avid listeners. Oh yeah, and they are, and you know what,
- 35:26Speaker 1: in fairness to them, an awful lot of behind the
- 35:29Speaker 1: bastards listeners need a lot of oil refined. I mean
- 35:31Speaker 1: I get that. I get a fan email in me
- 35:33Speaker 1: every week saying like, I have all this crude oil
- 35:36Speaker 1: and no way to refine it. Do you know where
- 35:38Speaker 1: I can do that in such a way that it
- 35:39Speaker 1: pollutes the Bay of Galveston beyond ecological salvage. And I'd
- 35:44Speaker 1: say the Koke Brothers, Oh wow, yeah, yeah, that's great
- 35:47Speaker 1: for that. So if you need your crude oil refined,
- 35:50Speaker 1: check out the Koke Brothers refineries. And if you need
- 35:54Speaker 1: anything else that we advertise products, we're back. So as
- 36:05Speaker 1: I was saying, doctors are not dumb, and many of
- 36:06Speaker 1: them were hesitant about some of the claims Perdue was
- 36:08Speaker 1: making They were particularly concerned about whether or not oxycontent
- 36:11Speaker 1: caused euphoria. If you've never taken opiates recreationally, you should
- 36:15Speaker 1: know that they have a strong mood altering component. Pain
- 36:18Speaker 1: Killers work on your emotions too. You feel very happy,
- 36:21Speaker 1: especially when coming up. It's kind of incredible. Of course,
- 36:24Speaker 1: this is something that concerns doctors because euphoria is the
- 36:26Speaker 1: most addictive thing in the world. Like if OxyContin caused it,
- 36:30Speaker 1: then that that might make it too dangerous to prescribe.
- 36:32Speaker 1: All willie nilly. Thankfully Perdue was there to lie to
- 36:35Speaker 1: doctors and say their pills did not cause euphoria. Sometimes
- 36:39Speaker 1: they'd admit that it could, but that it did so
- 36:41Speaker 1: less than other opiates, which of course there was no
- 36:44Speaker 1: evidence for. During the deposition, Richard Sackler was confronted with
- 36:47Speaker 1: a nineteen ninety note from a company salesman admitting that
- 36:50Speaker 1: he quote talked of less euphoria when selling the drug
- 36:52Speaker 1: to a doctor. Sackler argued in court that this was
- 36:55Speaker 1: fine because nine was before there was quote an agreed
- 36:58Speaker 1: statement of facts now in legally's an agreed statement of
- 37:02Speaker 1: facts is a list of facts both parties in a
- 37:04Speaker 1: lawsuit agree on and submit to a judge at the
- 37:06Speaker 1: start of a case. So, if I understand right, Richard
- 37:08Speaker 1: Sackley was saying it was fine for his employees to
- 37:11Speaker 1: light at doctors about the fact that his pain medicine
- 37:13Speaker 1: didn't cause euphoria because the company hadn't been sued yet
- 37:16Speaker 1: and so there wasn't an agreed upon statement of facts
- 37:18Speaker 1: like that. I think that's the argument he was making.
- 37:21Speaker 1: I'm not a lawyer. I'm not a murderer because I
- 37:23Speaker 1: haven't been I haven't been caught. You have you seen
- 37:26Speaker 1: me kill anyone in this courtroom today? I rest my case.
- 37:32Speaker 1: Ignore the blood on my shirt. Now. When the lawyer
- 37:35Speaker 1: for the state asked, what difference does that make if
- 37:37Speaker 1: it's improper in two thousand seven, wouldn't it be improper
- 37:40Speaker 1: in exactly, replied not necessarily. That's it. So you got
- 37:46Speaker 1: a say in court? Yeah. I always pictured court much
- 37:49Speaker 1: different than that. The state did present him with more memos,
- 37:51Speaker 1: and Sackly defended himself by saying that the claim of
- 37:53Speaker 1: less euphoria could be true and I don't see the
- 37:56Speaker 1: harm m I'm gonna quote from pro public again. The
- 38:00Speaker 1: same issue came up regarding a note written by a
- 38:01Speaker 1: produced sales representative about one doctor got to convince him
- 38:04Speaker 1: to counsel patients that they won't get buzzed as they
- 38:06Speaker 1: will with short acting opioid pain killers. Sackly defended these
- 38:09Speaker 1: comments as well, Well, what it says there is that
- 38:12Speaker 1: they won't get a buzz, and I don't think that
- 38:13Speaker 1: telling a patient I don't think you'll get a buzz
- 38:15Speaker 1: is harmful, he said. Sackler added that the comments from
- 38:18Speaker 1: the representative to the doctor actually could be helpful because
- 38:20Speaker 1: maybe patients won't get a buzz, and if you would
- 38:23Speaker 1: like to know if they do. He might have had
- 38:24Speaker 1: a good medical reason for wanting to know that, maybe
- 38:27Speaker 1: because he want to know if they were gonna get
- 38:28Speaker 1: addicted or not telling them won't get a buzz will
- 38:30Speaker 1: cause you to prescribe an addictive drug to people about
- 38:33Speaker 1: thinking we'll get them addictive, because if you're not getting
- 38:35Speaker 1: a buzz, then why would you do it addictive? Exactly
- 38:38Speaker 1: if it's not going to give you a buzz. Once
- 38:39Speaker 1: they develop a pain killer that doesn't get you high,
- 38:43Speaker 1: that's great, Like I mean, and I say, this is
- 38:45Speaker 1: the guy who loves getting high on pain killers. That's
- 38:46Speaker 1: like one of the best medicines you could possibly invent
- 38:49Speaker 1: is something that just stops pain and doesn't have an
- 38:52Speaker 1: abuse potential, which is what they were saying oxy content was.
- 38:56Speaker 1: But you know, drive through the Midwest you will see
- 38:59Speaker 1: that it is not. It causes so much pain. Yeah,
- 39:02Speaker 1: it really does. It's a nightmarish Now, between two thousand
- 39:07Speaker 1: and one, the number of oxy content prescriptions in the
- 39:08Speaker 1: US went from three hundred thousand to six million. Now
- 39:12Speaker 1: this might sound to you if your podcast, Alchemy this
- 39:14Speaker 1: went from three hundred thousand downloads in a week to
- 39:17Speaker 1: six million. I assume everybody at Alchemy this would be happy.
- 39:19Speaker 1: I know I'd be happy. I mean, so if he
- 39:21Speaker 1: we'd be super psyched. Richard Sackler was not happy with this.
- 39:24Speaker 1: In one employee, Michael Friedman told him that Perdue was
- 39:27Speaker 1: now making more than twenty million dollars a week. Sackler
- 39:30Speaker 1: replied instantly to his email after midnight that sales were,
- 39:33Speaker 1: in his opinion, not so great. After all, if we
- 39:36Speaker 1: are to do nine million this year, we should be
- 39:38Speaker 1: running at seventy million a month, So it looks like
- 39:40Speaker 1: this month it could be eighty or ninety million. Blah humbug, yawn.
- 39:44Speaker 1: Where was I wow, only twenty million a week. Man,
- 39:49Speaker 1: you can take it with you. It's you can't take
- 39:51Speaker 1: it with you at a certain point everyone, as far
- 39:55Speaker 1: as I know, unless Perdue is figured out a cure,
- 39:57Speaker 1: you're gonna have to leave it all behind. Yeah, you
- 40:00Speaker 1: can't spend all that, But I'd sure like to be
- 40:04Speaker 1: challenged to. I mean, I feel like if I made
- 40:07Speaker 1: twenty million dollars in a lifetime, that would allow me
- 40:10Speaker 1: to live beyond my wildest dreams. That's enough money, for example,
- 40:14Speaker 1: three months rent in the bank today. I wouldn't be
- 40:17Speaker 1: crying myself home. This is one of those things I
- 40:20Speaker 1: don't tend to. I think it's actually dangerous to like
- 40:22Speaker 1: talk jokingly too much about like guillotines and stuff. But
- 40:25Speaker 1: like when you look at people living this way and
- 40:26Speaker 1: then you realize that, like some like Americans have listened
- 40:29Speaker 1: a thousand dollars in the bank, it's like, what do
- 40:31Speaker 1: you think this is going to end? Buddy? Like you're
- 40:33Speaker 1: selling poison to people and you're not happy at twenty
- 40:36Speaker 1: million a week, And there's people like worried that they
- 40:39Speaker 1: have to choose between insulin and food for the month, Like,
- 40:42Speaker 1: what do you think the long term is on this
- 40:44Speaker 1: like it's frustrating. It's like and that's the nicest way
- 40:49Speaker 1: you could put it. That's the nicest, very frustrating. Now,
- 40:54Speaker 1: by two thoe Perdu held more than half of the
- 40:56Speaker 1: market share for long acting opioids. That year was also
- 40:58Speaker 1: the first year annual sales of oxycontent broke one billion dollars,
- 41:02Speaker 1: So in the span of five years, oxyconton sales went
- 41:04Speaker 1: from forty eight million in a year to one billion
- 41:07Speaker 1: in a year. The New York Times article that announced
- 41:09Speaker 1: this noted that these sales were quote even more than viagra.
- 41:12Speaker 1: If you have found a way to sell people something
- 41:15Speaker 1: that they want more than erections, you're selling a drug,
- 41:18Speaker 1: like a dangerous druke. Like I feel like that's across
- 41:21Speaker 1: the board true now. That New York Times report also
- 41:24Speaker 1: noted that the drug had been involved in the deaths
- 41:27Speaker 1: of at least a hundred and twenty people. In the
- 41:29Speaker 1: year two thousand, the Sackler family was warned that a
- 41:31Speaker 1: journalist was quote sniffing around the oxycontent abuse story. The
- 41:34Speaker 1: family discussed this threat during their next board meeting in
- 41:37Speaker 1: CREDI this is only the year two thousand, We're just
- 41:39Speaker 1: up to two thousands I had, I had, I knew
- 41:43Speaker 1: somebody that died of oxycotton before the year two thousand.
- 41:47Speaker 1: How is there only a hundred and twenty people cases
- 41:49Speaker 1: of people dead? Oh, there were more, but like that,
- 41:52Speaker 1: this is just what they confirmed. Like we're talking about
- 41:53Speaker 1: how journalists digging into it before this was common knowledge.
- 41:56Speaker 1: So they had found a hundred and twenty cases, but like,
- 41:59Speaker 1: obviously they were probably thousands at that point. Yeah, that's
- 42:01Speaker 1: crazy that they're only starting to discover. I guess in
- 42:04Speaker 1: my world, I thought that that was something not to
- 42:07Speaker 1: go to. It's not my therapy session. But when I
- 42:09Speaker 1: was younger, people were taking oxy cotton and it was
- 42:13Speaker 1: not that bad. Like everybody's like, oh, this is just
- 42:15Speaker 1: ability to give from the doctor's office. And they abused
- 42:17Speaker 1: the ship out of it, and it's like, well, at
- 42:18Speaker 1: least it's not Heroin. But then then obviously the next
- 42:21Speaker 1: step is Heroine. The next step is Heroin. Then you
- 42:23Speaker 1: wind up in that finton All ship and then you die.
- 42:26Speaker 1: I don't think fenton All is around when I was
- 42:28Speaker 1: that's now, yeah, they were just moving to Heroin. God. Yeah, sorry.
- 42:33Speaker 1: When I hear them say people dead in two thousand
- 42:36Speaker 1: I'm like, that can't be. That was just like who
- 42:39Speaker 1: the New York Times could confirm. It's like, I assume
- 42:41Speaker 1: it was a lot of leg work behind. Probably I
- 42:44Speaker 1: wouldn't be surprised if maybe the pharmaceutical company was trying
- 42:47Speaker 1: to hide it. That's exactly what we're about to get to.
- 42:49Speaker 1: So the family discussed this threat during their next board
- 42:51Speaker 1: meeting and crafted a response that was their Their goal
- 42:54Speaker 1: was that the response quote deflects attention away from the
- 42:56Speaker 1: company owners. So the Sacklers made up the majority of
- 43:00Speaker 1: the Purdue board. When you hear their journals is sniffing around,
- 43:03Speaker 1: it's like, okay, well, they're gonna probably figure out that
- 43:06Speaker 1: a lot of people are dying on oxy But we
- 43:07Speaker 1: gotta keep our names out of this ship. We don't
- 43:09Speaker 1: want to hurt the family sound a little bit like
- 43:11Speaker 1: the mob. Shortly thereafter, Time put together an article on
- 43:14Speaker 1: OxyContin deaths. Concerned Purdue employees asked Richard Sackler, then the CEO,
- 43:18Speaker 1: about this. He wrote that the Times coverage was not
- 43:21Speaker 1: quote balanced, blamed the deaths on drug addicts, and assured
- 43:24Speaker 1: them we intend to stay the course and speak out
- 43:26Speaker 1: for people in pain who far outnumber the drug addicts
- 43:29Speaker 1: abusing our product. Wow, that sounds like such a familiar tone. Yeah,
- 43:34Speaker 1: I don't know. It's reminiscent of arguments have heard from
- 43:36Speaker 1: idiots to yeah, unnamed idiots. Yeah. In two thousand one,
- 43:41Speaker 1: there were about eight drug overdose deaths for every hundred
- 43:43Speaker 1: thousand Americans. By two thousand ten, that number had almost
- 43:46Speaker 1: doubled to fifteen deaths per hundred thousand. On a national scale,
- 43:50Speaker 1: this equated to tens of thousands of new dead people,
- 43:53Speaker 1: and most of them were dying from opiate pain killers,
- 43:55Speaker 1: including OxyContin. Now, many of them were actually oding on heroin,
- 43:59Speaker 1: but it just so happened that most of those deaths were,
- 44:01Speaker 1: of course, folks who got hooked initially on an opiate
- 44:03Speaker 1: pain killer like our good friend OxyContin. In January of
- 44:06Speaker 1: two thousand one, Richard Sackler received a request for help
- 44:09Speaker 1: from a produced sales associate. The rep had been to
- 44:12Speaker 1: a community meeting at a local high school convened by
- 44:14Speaker 1: a group of mothers whose kids had all overdosed and
- 44:16Speaker 1: died on OxyContin. Quote statements were made that OxyContin sales
- 44:20Speaker 1: were at the expense of dead children, and the only
- 44:21Speaker 1: difference between heroine and OxyContin is that you can get
- 44:24Speaker 1: oxycontent from a doctor. The very next month, a story
- 44:27Speaker 1: dropped that fifty nine people had died in a single
- 44:29Speaker 1: month from OxyContin in the state of Massachusetts. Richard's response
- 44:32Speaker 1: was this quote, this is not too bad. It could
- 44:35Speaker 1: have been worse. Yeah, it could have been more bable
- 44:38Speaker 1: it will be soon. Very next week, a mother wrote
- 44:40Speaker 1: a letter to Perdue Pharmaceutical stating quote, my son was
- 44:43Speaker 1: only twenty eight years old when he died from OxyContin
- 44:46Speaker 1: on New Year's Day. We all miss him very much,
- 44:48Speaker 1: his wife, especially on Valentine's Day. Why would a company
- 44:50Speaker 1: make a product that strong eighty and hundred and sixty
- 44:53Speaker 1: milgram when they know it will kill young people. My
- 44:55Speaker 1: son had a bad back and could have taken motrin,
- 44:57Speaker 1: but his doctor started him on vicodin, then ox content
- 45:00Speaker 1: than OxyContin s R. Now he is dead. A produced
- 45:04Speaker 1: staff member responded to this by saying, simply, I see
- 45:07Speaker 1: a liability issue here, any suggestions that was like the
- 45:10Speaker 1: company responses like other moms, we might. We might get
- 45:14Speaker 1: sued over this, like no other concerns. Later that month,
- 45:17Speaker 1: Richard Sackler finally came up with a solution to this problem,
- 45:20Speaker 1: so many people were whining about for some reason, He
- 45:22Speaker 1: wrote in a confidential company email quote, we have to
- 45:25Speaker 1: hammer on the abusers in every way possible. They are
- 45:27Speaker 1: the culprits and the problem. They are reckless animals. According
- 45:31Speaker 1: to a State of Massachusetts lawsuit filed like this year quote,
- 45:35Speaker 1: Richard followed that strategy for the rest of his career,
- 45:37Speaker 1: collect millions from selling addictive drugs, and blame the terrible
- 45:40Speaker 1: consequences on the people who became addicted by their misconduct.
- 45:43Speaker 1: The Sacklers have hammered Massachusetts families in every way possible,
- 45:46Speaker 1: and the stigma they used as a weapon made the
- 45:48Speaker 1: crisis worse. So get people addicted to a drug, then
- 45:53Speaker 1: encourage the criminalization of that abuse, and attack the users themselves,
- 45:58Speaker 1: which will of course make people less likely to get help,
- 46:00Speaker 1: which will make them more likely to when you're actually
- 46:03Speaker 1: a victim, keeps you buying. The only thing that would
- 46:05Speaker 1: make it worse is if the Sackler family started investing
- 46:08Speaker 1: in privatized prisons. They didn't. I mean, actually they may
- 46:12Speaker 1: have a lot of their money is dark, but we
- 46:14Speaker 1: will get to what they spend their money off a
- 46:16Speaker 1: little bit later. Yeah, I don't tell me it's pretty bad.
- 46:20Speaker 1: This strategy worked for a little while, but by two
- 46:22Speaker 1: thousand ten, the nation has started to wake up to
- 46:23Speaker 1: the dangerous of boxy content, and Purdue was forced to
- 46:25Speaker 1: carry out what Esquire describes as a breathtaking pivot quote
- 46:29Speaker 1: Embracing the arguments critics have been making for years about
- 46:31Speaker 1: oxycontinent susceptibility to abuse, the company released a new formulation
- 46:35Speaker 1: of the medication that was harder to snort or inject.
- 46:37Speaker 1: Produce sees the occasion to rebrand itself as an industry
- 46:40Speaker 1: leader in abuse to turrent technology. The change of heart
- 46:43Speaker 1: coincided with two developments. First, an increasing number of addicts
- 46:46Speaker 1: unable to afford Oxycontinent's high street price. We're turning this
- 46:49Speaker 1: cheaper alternatives like heroin. Second, oxycontent was nearing the end
- 46:52Speaker 1: of its patents. Produced suddenly argued that the drug it
- 46:55Speaker 1: had been selling for nearly fifteen years was so prone
- 46:57Speaker 1: to abuse the generic manufacturers should not be allowed to
- 47:00Speaker 1: copy it. Three years later, on April sixteenth, two thousand thirteen,
- 47:05Speaker 1: the day several OxyContin patents were set to expire, the
- 47:08Speaker 1: FDA gave Purdue what they wanted, banning anyone else from
- 47:11Speaker 1: selling generic oxy content produce basically extended the profitability of
- 47:15Speaker 1: their chief cash cow by arguing that it was too
- 47:17Speaker 1: dangerous to let anyone else sell. And did that stand. Yeah,
- 47:21Speaker 1: So now have mixed feelings. I think it's awful and
- 47:25Speaker 1: there should not be generic versions of oxycotton out there.
- 47:29Speaker 1: Uh so less it's better no matter how if you
- 47:31Speaker 1: don't want to just give more weapons to people just
- 47:33Speaker 1: because one person has it. Do you think, And it's
- 47:36Speaker 1: probably impossible to say that lives were saved by not
- 47:39Speaker 1: giving that patent generic like options. I doubt it. I
- 47:43Speaker 1: seriously doubt it. I like, I don't think it did
- 47:47Speaker 1: anything but allow Perdue to keep profiting from it. Like
- 47:50Speaker 1: if there was any reducing loss of life from that,
- 47:54Speaker 1: it was canceled out from the fact that they were
- 47:57Speaker 1: marketing this and pushing it so heavily to doctors and
- 47:59Speaker 1: continuing to do so and continuing to try to get
- 48:01Speaker 1: it on the market because like it was. I wouldn't
- 48:04Speaker 1: give them any credit for that. I can't give them
- 48:06Speaker 1: credit because it's just out of greed. But I just
- 48:08Speaker 1: wonder what would have happened if it was opened up
- 48:10Speaker 1: to generic markets. You don't have been even more abused.
- 48:13Speaker 1: You could argue that it might have made the situation
- 48:16Speaker 1: better because yeah, it's cheaper, but also that means that
- 48:19Speaker 1: addicts aren't gonna bankrupt themselves doing it. They're not going
- 48:23Speaker 1: to have to steal ship in order to afford it.
- 48:25Speaker 1: And like, you know, you do find that when there's
- 48:29Speaker 1: places I think Denmarks one of them, more they'll give
- 48:31Speaker 1: heroin addicts free heroin, like the government will, and you, like,
- 48:33Speaker 1: you go to a government clinic and they'll they'll give
- 48:36Speaker 1: you the heroine to inject and stuff, and they find
- 48:39Speaker 1: out that number one, it doesn't create more addicts. In
- 48:41Speaker 1: number two, the government saves money because they're not out
- 48:43Speaker 1: committing crimes. They're not breaking into houses and stealing ship
- 48:46Speaker 1: in order to like, So you could argue that it
- 48:48Speaker 1: again made things worse on the addicts by they're not
- 48:51Speaker 1: being a generic available even though it's not great for
- 48:53Speaker 1: people to be addicted oxy it's one of those hard
- 48:55Speaker 1: questions that is above my brain scale. And you also
- 48:57Speaker 1: might argue that it killed more people because the content
- 49:00Speaker 1: is safer than heroin, and if you can't afford OxyContin,
- 49:04Speaker 1: you're just gonna go to heroin or fentonylum so that's true. Yeah,
- 49:07Speaker 1: you could argue, if there was a cheap oxy maybe
- 49:10Speaker 1: we'd have a few more addicts, but we'd have less overdoses.
- 49:12Speaker 1: So yeah, I think they might have killed more people
- 49:15Speaker 1: that way. Now. Richard Sackler's personal attitude towards the harm
- 49:18Speaker 1: his drug was doing is illustrated by the case of
- 49:20Speaker 1: Purdue Germany. According to pro Publica quote, Sackler pushed company
- 49:24Speaker 1: officials to find out if German officials could be persuaded
- 49:26Speaker 1: to loosen restrictions on the selling of OxyContin. In most countries,
- 49:30Speaker 1: narcotic pain relievers are regulated as controlled substances because of
- 49:33Speaker 1: the potential for abuse. Sackler and other Purdue executives discussed
- 49:36Speaker 1: the possibility of persuading German officials to classify oxycontent as
- 49:39Speaker 1: an uncontrolled drug, which would likely allow doctors to prescribe
- 49:42Speaker 1: the drug more readily, for instance, without seeing a patient.
- 49:45Speaker 1: Fewer rules were expected to translate into more sales, according
- 49:48Speaker 1: to company documents disclosed at the deposition. In other words,
- 49:52Speaker 1: in Germany and all across the EU, Richard Sackler's goal
- 49:55Speaker 1: was to be able to sell oxycontent not as a
- 49:57Speaker 1: prescription medication, but as an uncontrolled pain killer, and that's
- 50:00Speaker 1: not the same as over the counter. I think it's
- 50:02Speaker 1: a little different to have somebody tell you to get it,
- 50:05Speaker 1: but you don't necessarily have to go through a doctor visit. Yeah, yeah,
- 50:08Speaker 1: I think that's what that means. Like you don't have
- 50:09Speaker 1: to go to a like like a dot like. Yeah,
- 50:11Speaker 1: you can't like just pick it up, like you can't
- 50:13Speaker 1: and go out of mall for example. Um, but you
- 50:16Speaker 1: can you can get it without there being any of
- 50:18Speaker 1: the controls that we put on. Like was their argument
- 50:21Speaker 1: later that they were just simply into saying no Germany,
- 50:23Speaker 1: we were saying it was out of control. At least
- 50:26Speaker 1: out of control. They were the ones who made it.
- 50:28Speaker 1: I'm kind of surprised they didn't take that. Yeah. Robert Keiko,
- 50:32Speaker 1: one of the men who had actually developed oxycontent, warned
- 50:35Speaker 1: Richard Sackler when he learned this plan, quote, if oxy
- 50:37Speaker 1: content is uncontrolled in Germany, it is highly likely that
- 50:39Speaker 1: it will eventually be abused there and then controlled. Richard's
- 50:42Speaker 1: response to Keiko showed zero concern about the impact of
- 50:45Speaker 1: releasing an addictive drug uncontrolled onto an entire continent. How
- 50:49Speaker 1: substantially would it improve your sales? A lot, Yeah, a lot.
- 50:53Speaker 1: When the German government ruled that OxyContin would be treated
- 50:56Speaker 1: like any other addictive narcotic, Richard asked if it was
- 50:58Speaker 1: possible to appeal. A German produce executive told him that
- 51:01Speaker 1: this was not possible, and Sackler wrote back tersely, when
- 51:04Speaker 1: we are next together, we should talk about how this
- 51:06Speaker 1: idea was raised and why it failed to be realized.
- 51:08Speaker 1: I thought it was a good idea if it could
- 51:10Speaker 1: be done. How I'm sorry, what what year was this?
- 51:15Speaker 1: Just generally, is this more recent that this is like
- 51:17Speaker 1: in the late tooth that this is pretty recently? Yeah. So,
- 51:22Speaker 1: And I don't know a lot about Germany. You've never
- 51:24Speaker 1: been there, but I've worked in video games, and I
- 51:26Speaker 1: know that Germany has some strict rules on video games,
- 51:28Speaker 1: and people are bringing video games from outside so they
- 51:31Speaker 1: can get past, you know, certain readings. Now, I would
- 51:33Speaker 1: imagine that that means if these are uncontrolled substances, doesn't
- 51:37Speaker 1: that affect all the countries that are around Germany that
- 51:39Speaker 1: they would be flooded with oxycott? Sure it could have borders. Yeah,
- 51:44Speaker 1: Thankfully the Germans were like, took one look at the
- 51:47Speaker 1: U S and We're like, I don't think we want
- 51:51Speaker 1: that here. Yeah, yeah, we already we already had enough
- 51:54Speaker 1: of a problem with with with opiates in our past.
- 51:58Speaker 1: We're good, We're good. So that's what we got today.
- 52:01Speaker 1: When we come back on Thursday, we're gonna talk about,
- 52:03Speaker 1: among other things, the court case in two thousand and
- 52:06Speaker 1: seven against Produce Pharmaceutical, uh, the ongoing legal stuff now,
- 52:10Speaker 1: and of course we're gonna get a lot into the
- 52:12Speaker 1: marketing of oxy content, which we haven't really talked about
- 52:15Speaker 1: that much this episode, but there is quite a lot
- 52:17Speaker 1: to say. But that's all next Thursday. Do you want
- 52:21Speaker 1: to plug your plugables before? I mean, if you're still
- 52:24Speaker 1: if you didn't hear at the beginning because you were
- 52:26Speaker 1: fast forward and here it is Alchemy. This releases every
- 52:28Speaker 1: Tuesday and Thursday. It is funny. We get suggestions from
- 52:32Speaker 1: the audience and we make an improv show up. It's
- 52:34Speaker 1: with Kevin Pollock. Yes, that Kevin Pollock, and we have
- 52:37Speaker 1: a live show May seventh at the Dynasty Typewriter Theater
- 52:41Speaker 1: in Los Angeles. Please come so check it out Dynasty
- 52:43Speaker 1: Typewriter Theater, May seventh. James Heeney, you want to plug
- 52:47Speaker 1: any of your your social media Oh yeah, you can
- 52:49Speaker 1: find me at the heen t H H E A M.
- 52:53Speaker 1: That's on Twitter. Uh. And a great way to find
- 52:55Speaker 1: me is Brief newsbrief dot com and has all the
- 52:57Speaker 1: different ways to get ahold of me awesome. Well, check
- 53:00Speaker 1: out James Heeney on the internet and check out this
- 53:02Speaker 1: podcast on the web and Behind the Bastards dot com. Um,
- 53:05Speaker 1: check us out on Twitter and the Graham at Bastards
- 53:10Speaker 1: pod and buy a shirt. You could buy a cup holder. Uh,
- 53:15Speaker 1: you could buy an SPG nine recoilist rifle branded with
- 53:19Speaker 1: Behind the Bastard's logo and uh, and equipment in case
- 53:22Speaker 1: you've got to take out of T seventy two. You know,
- 53:24Speaker 1: like like we all find ourselves needing to do at
- 53:26Speaker 1: some point. So what else? What else we doing? Is
- 53:28Speaker 1: that all the plugs? Oh? I have another show called
- 53:31Speaker 1: it Could Happen Here. It could happen in your been
- 53:35Speaker 1: listening to the ads for It's not out yet, is it? Oh?
- 53:37Speaker 1: It is? Oh my gosh, I'm super excited about the
- 53:39Speaker 1: Civil War could happen here in the station and uh
- 53:43Speaker 1: spoiler you don't want it to know, I'm not it
- 53:47Speaker 1: wouldn't be good. I actually I'm really excited to listen
- 53:50Speaker 1: to it. I'm still I'm embarrassed. I'm still finishing up
- 53:52Speaker 1: End of the World. But once I'm done with that,
- 53:54Speaker 1: that's my next one. Well, uh, make it your next one, listener,
- 53:58Speaker 1: because it will make you sad and scared, and we
- 54:01Speaker 1: all want to be sad and scared, don't we. All right, well,
- 54:04Speaker 1: we'll be back Thursday. I'm very hungover right now. So
- 54:07Speaker 1: this has been a little bit of a scattered scattered
- 54:09Speaker 1: brain episode. Sophie's saying she's very aware of this fact. Yeah, yeah,
- 54:14Speaker 1: all right, Well this is at the end of the episode.
- 54:17Speaker 1: Daniel's looking at me like when, when then are you
- 54:19Speaker 1: gonna stop? And uh, it's now right now, right this
- 54:22Speaker 1: moment now, m